PD Dr. Agnes Bosch

Medizinische Fakultät Department of Medicine 4 – Nephrology and Hypertension

Novel approaches to management of hypertension (2021) Bosch A, Schmieder R Journal article, Review article Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography (2020) Jung S, Bosch A, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder R Journal article Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes (2020) Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, et al. Journal article Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes (2019) Jung S, Bosch A, Kannenkeril D, Karg M, Striepe K, Bramlage P, Ott C, Schmieder R Conference contribution Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes (2019) Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R Conference contribution Disparate effects of the combined therapy of empagliflozin and linagliptin versus metformin and insulin glargine on renal haemodynamics in type 2 diabetes (2019) Ott C, Jung S, Kannenkeril D, Striepe K, Bosch A, Korn M, Bramlage P, Schmieder R Conference contribution IMPACT OF BLOOD PRESSURE AND AGEING ON RETINAL NEURODEGENERATION ASSESSED BY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY (2019) Jung S, Bosch A, Kohler N, Ott C, Kannenkeril D, Dienemann T, Harazny JM, et al. Conference contribution DISPARATE NITRIC OXIDE ACTIVITY OF THE RETINAL CIRCULATION IN HYPERTENSIVE VS TYPE 2 DIABETES-PATIENTS (2019) Kannenkeril D, Jung S, Harazny JM, Bosch A, Ott C, Schmieder R Conference contribution THE INFLUENCE OF ANNOYANCE DUE TO AIRCRAFT NOISE ON RENAL HEMODYNAMIC (2019) Bosch A, Kannenkeril D, Ott C, Harazny JM, Striepe K, Karg MV, Jung S, Schmieder R Conference contribution EFFECTS OF THE NO SYNTHASE INHIBITOR RONOPTERIN (VAS203) ON MICRO- AND MACROCIRCULATION IN HEALTHY VOLUNTEERS (2019) Ott C, Bosch A, Jung S, Kannenkeril D, Schinzel R, Tegtmeier F, Schmieder R Conference contribution